Skip to main content
OpenTrials

Clinical trial condition

Chorea

Explore clinical trials studying Chorea. Study availability and eligibility vary by location and protocol.

209 public trials 38 recruiting studies
Refine in advanced search Browse all conditions

Chorea trial results

Completed

An Open Label Study of ANX005 in Participants With, or at Risk for, Manifest Huntington's Disease

NCT04514367

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Annexon Investigational Site 02 Birmingham, Alabama, United States
  • Annexon Investigational Site 03 Englewood, Colorado, United States
  • Annexon Investigational Site 04 Washington D.C., District of Columbia, United States
  • Annexon Investigational Site 07 Durham, North Carolina, United States
View Trial Details
Completed

Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers

NCT06667414

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +13 more
Locations
  • Uab Medicine Birmingham, Alabama, United States
  • Barrow Neurological Institute Phoenix, Arizona, United States
  • University of California San Diego La Jolla, California, United States
  • University of California Davis Medical System Sacramento, California, United States
View all 45 locations
View Trial Details
Completed

Research of Biomarkers in Parkinson Disease

NCT00465790

Conditions
Autonomic Nervous System Diseases, Basal Ganglia Diseases, Brain Diseases, +34 more
Locations
  • Meditterranean Institute for Life Sciences Split, Croatia
  • INSERM Unit 679 Paris, France
  • University of Lübeck and Neuroimage Nord Lübeck, Germany
  • University Hospital Tübingen Tübingen, Germany
View Trial Details
Completed

Open-Label Rollover Study for Continuing Valbenazine Administration for the Treatment of Chorea Associated With Huntington Disease

NCT04400331

Conditions
Basal Ganglia Diseases, Brain Diseases, Central Nervous System Diseases, +14 more
Locations
  • Neurocrine Clinical Site Birmingham, Alabama, United States
  • Neurocrine Clinical Site Little Rock, Arkansas, United States
  • Neurocrine Clinical Site La Jolla, California, United States
  • Neurocrine Clinical Site Aurora, Colorado, United States
View all 34 locations
View Trial Details

Related conditions